HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bobbi Brown

This article was originally published in The Rose Sheet

Executive Summary

Shine Control Hydrating Face Gel keeps oily complexions in check while leaving skin hydrated, the company claims. Gentle enough for sensitive skin, the lightweight, water-based formula contains algae extracts and powder to help absorb oil and give skin a matte finish. The face gel retails for $38. Revitalizing Eye Gel is a water-based formula to "help diminish fine lines and restore elasticity" around the delicate eye area. The company's custom-designed airless pump bottle is said to "insure maximum hygiene." Both products, available in March, will retail for $38 and $32.50, respectively. Rounding out Bobbi Brown's spring offerings are Sunless Tanning Face Gel, available in February for $16.50, and Waterproof Eye Makeup remover formulated with cucumber extracts for $16.50, which will be on-counter in April

Latest Headlines
See All
UsernamePublicRestriction

Register

RS006218

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel